Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

404 trials

NCT07536503
Recruiting
Effects of Sleep Quality on Functional and Cognitive Outcomes in Multiple Sclerosis
Not applicable · 1 site
Registry update: 2 Jun 2026
NCT06864936
Recruiting
Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
Not applicable · United States · 1 site
Registry update: 29 Jul 2026
NCT07497399
Recruiting
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Phase 2 · United States · 3 sites
Registry update: 5 Nov 2026
2025-521546-23-00
Recruiting
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Phase 3 · Austria, Belgium, Bulgaria, Czechia, Germany, Denmark, Estonia, Spain, Finland, France, Greece, Croatia, Hungary, Ireland, Italy, Lithuania, Latvia, Netherlands, Norway, Poland, Portugal, Romania, Sweden, Slovenia, Slovakia · 184 sites
Registry update: 30 Jul 2026
NCT07549048
Recruiting
Caregiver Burden in Caregivers of Patients With Multiple Sclerosis
Not applicable · 1 site
Registry update: 23 Apr 2026
NCT06796504
Recruiting
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Not applicable · United States · 9 sites
Registry update: 2 Sept 2026
NCT07304154
Recruiting
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
Phase 1 · Australia, Canada, United States · 10 sites
Registry update: 19 Oct 2026
NCT07779460
Recruiting
A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice
Not applicable · United States · 1 site
Registry update: 21 Aug 2026
NCT06919900
Recruiting
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
Not applicable · United States · 1 site
Registry update: 17 Jun 2026
NCT07526493
Recruiting
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Phase 1 · China · 1 site
Registry update: 12 May 2026
NCT07614321
Recruiting
Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
Phase 4 · United States · 1 site
Registry update: 29 May 2026
NCT07571304
Recruiting
Dual-Task Training in Pediatric Multiple Sclerosis
Not applicable · 1 site
Registry update: 6 May 2026
NCT07503873
Recruiting
A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)
Phase 2 · Georgia, North Macedonia, Poland, Serbia, Ukraine · 30 sites
Registry update: 29 Oct 2026
NCT07178431
Recruiting
MB-CART2019.1 in Refractory Multiple Sclerosis
Phase 1/2 · Germany · 1 site
Registry update: 11 May 2026
2024-517601-82-00
Recruiting
MB-CART2019.1 in refractory MS
Phase 1/2 · Germany · 2 sites
Registry update: 18 Sept 2026
NCT07252895
Recruiting
EXOPULSE Suit and Walking Ability of Patients With Multiple Sclerosis
Not applicable · France · 11 sites
Registry update: 6 Apr 2026
NCT07299019
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Phase 3 · Austria, Australia, Belgium, Bulgaria, Czechia, Germany, Denmark, Estonia, Spain, France, Georgia, Greece, Croatia, Hungary, Italy, Lithuania, Netherlands, Norway, Poland, Puerto Rico, Portugal, Romania, Serbia, Sweden, Slovenia, Slovakia, Ukraine, United States · 176 sites
Registry update: 4 Nov 2026
NCT07067463
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Phase 3 · Austria, Australia, Belgium, Bulgaria, Czechia, Germany, Denmark, Estonia, Spain, Finland, France, Georgia, Greece, Croatia, Hungary, Italy, Netherlands, Poland, Puerto Rico, Portugal, Romania, Serbia, Sweden, Slovakia, Ukraine, United States · 155 sites
Registry update: 3 Nov 2026
NCT07736482
Recruiting
Relationship Between Single- and Dual-Task Obstacle Crossing Performance and Fatigue and Disability in Multiple Sclerosis
Not applicable · 1 site
Registry update: 31 Jul 2026
NCT07289724
Recruiting
How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.
Not applicable · France · 1 site
Registry update: 13 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.